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Abstract—Barangcadoic acid A (1) and rhopaloic acids D (5) to G (8), novel terpenoids with RCE protease inhibitory activity,
have been isolated from the marine sponge Hippospongia sp. collected in Indonesia. The structures of 1 and 5–8 were elucidated
by analysis of spectroscopic data. © 2002 Elsevier Science Ltd. All rights reserved.
Ras is a membrane bound G protein that functions as
a molecular switch in a network of signaling pathways
controlling cell differentiation and proliferation.1–3 In
cancer cells, unregulated cell signaling and proliferation
may occur through overexpression or mutation of
proto-oncogenes. Mutated Ras genes, which constitu-
tively encode activated Ras proteins, have been iden-
tified in approximately 30% of all human cancers. As a
result, the Ras signaling pathway has been identified as
an important target for the development of anticancer
drugs.1–3
Ras must be membrane bound to be active. A series of
post-translational modifications at the C terminus
CAAX motif of Ras increases its membrane affinity.
First the protein is prenylated at the cysteine residue
with either farnesyl or geranylgeranyl residues, then a
specific protease cleaves the –AAX tripeptide from the
protein, and finally the cysteine carboxyl group is
methylated. Each processing step significantly increases
the affinity of farnesylated proteins for membranes. To
date, most approaches to therapeutic intervention in
the Ras signaling pathway have focused on develop-
ment of farnesyl transferase (Ftase) inhibitors that
block the lipid modification needed for proper Ras
membrane localization. Ras proteolysis also represents
a promising target for disrupting Ras signaling. The
recent characterization of hRCE1 (human Ras-convert-
ing enzyme),2 which is responsible for proteolytic pro-
cessing of Ras, led to the development of an assay to
screen for RCE protease inhibitors.3 Crude EtOH
extracts of the Indonesian sponge Hippospongia sp.
showed promising activity in the RCE protease assay.
Bioassay guided fractionation of the extracts led to the
identification of barangcadoic acid A (1) and rhopaloic
acids A (2) to G (8), a family of terpenoids with RCE
protease inhibitory activity. Details of the isolation,
structure elucidation, and biological activities of the
novel terpenoids 1 and 5–8 are presented below.
Hippospongia sp., was harvested by hand using SCUBA
on the inner reef at Barangcadi Island, Ujung Pandang,
Sulawesi, Indonesia. Freshly collected sponge (60 g)
was repeatedly extracted with EtOH. The combined
extracts were concentrated in vacuo, and the resulting
aqueous suspension was partitioned between H2O and
EtOAc. Bioassay guided fractionation of the RCE-
protease inhibitory EtOAc soluble material by sequen-
tial application of Sephadex LH20 chromatography
(eluent: 80% MeOH/CH2Cl2), reversed-phase flash gra-
dient column chromatography (eluent: 100% H2O to
100% MeOH) and reversed-phase HPLC (eluent: 65%
MeCN/(0.05%TFA/H2O)) yielded pure barangcadoic
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acid A (1) and rhopaloic acids A (2) to G (8) as clear
oils.
Barangcadoic acid A (1) (35 mg) gave a [M−H]− ion at
m/z 403.2846 in the negative ion HRFABMS spectrum
that was appropriate for a molecular formula of
C25H40O4. The 1H, 13C, COSY, HMQC, and HMBC
NMR data4 obtained for 1 readily identified a carboxyl
group (13C ! 169.7), an olefinic methylene (1H ! 6.36,
bs, H-21; 5.92, ds, H-21!: 13C ! 141.0 (C-2): 126.7
(C-21)), three trisubstituted olefins (1H ! 5.40, t, J=6.3
Hz, H-19; 5.08, m, H-15; 5.06, m, H-11: 13C ! 140.0
(C-18), 135.3 (C-14), 134.7 (C-10), 124.4 (C-11), 123.9
(C-15), 123.2 (C-19)), an oxygenated methine carbon
(1H ! 4.10, d, J=10.7 Hz, H-3: 13C ! 75.9 (C-3), two
oxygenated methyl residues (1H ! 4.15, d, J=6.3 Hz,
H-20/H-20!; 4.02, ddd, J=11.4, 2.7, 0.8 Hz, H-22eq;
3.13, t, J=11.4 Hz, H-22ax: 13C ! 74.0 (C-22), 59.4
(C-20) and three allylic methyls (1H ! 1.66, s, Me-25;
1.58, s, Me-24; 1.55, s, Me-23: 13C ! 16.3 (C-25), 10.0,
15.9 (C-23/C-24)). These functionalities accounted for
only five of the six sites of unsaturation required by the
molecular formula, indicating that 1 also contained a
ring.
HMBC correlations observed between a 1H resonance
at ! 4.10 (H-3) and 13C resonances assigned to the
carboxyl (! 169.7: C-1) and olefinic methylene (! 141.0:
C-2 and 126.7: C-21) groups, and between the olefinic
methylene protons at ! 6.36 (H-21) and 5.92 (H-21!)
and 13C resonances at ! 169.7 (C-1), 141.0 (C-2), and
75.9 (C-3) established that the carboxyl group (C-1)
and the oxygenated methine carbon (C-3) were geminal
substituents on the fully substituted carbon (C-2) of the
olefinic methylene fragment. HMQC, COSY, and
HMBC data routinely established the connectivity from
C-3 to C-6 and C-22. HMBC correlations between H-3
(! 4.10) and the oxygenated methyl carbon resonating
at ! 74.0 (C-22) and between the geminal protons at !
4.02 and 3.13 (H-22eq and H-22ax) and the C-3 reso-
nance at ! 75.9 established the presence of a six-mem-
bered ether ring.
COSY correlations observed between the olefinic pro-
ton resonance at ! 5.40 (t, J=6.9 Hz; H-19) and both
the methylene proton resonance at ! 4.15 (d, J=6.9 Hz;
H-20/H-20!) and a methyl resonance at ! 1.66 (bs:
Me-25) showed that the second oxygenated methyl
(C-20) and another methyl (Me-25) were vicinal sub-
stituents on a trisubsituted olefin. HMBC correlations
observed between the olefinic resonance at ! 5.40 (H-
19) and carbon resonances at ! 59.4 (CH2; C-20), 16.3
(CH3; C-25) and 39.7 (CH2; C-17) confirmed this
assignment and identified an aliphatic methylene car-
bon (C-17) as the third substituent on the trisubstituted
olefin. Two overlapping olefinic resonances at ! 5.06
(H-11) and 5.08 (H-15), which both appeared as broad
triplets (J!7 Hz), showed COSY correlations to
olefinic methyl resonances at ! 1.66 (Me-23) and 1.58
(Me-24), respectively, and to the clusters of allylic
methylene proton resonances at ! 1.92–2.07 and !
2.01–2.12. These COSY correlations identified two
additional trisubstituted olefins, each having one methyl
and two aliphatic methylene carbons as substituents.
HMBC and COSY correlations confirmed that the
three trisubsituted olefins comprised the regular ter-
penoid fragment extending from C-9 to C-20.
A well resolved methylene proton resonance at ! 1.07
(H-7) showed HMBC correlations to carbon resonances
at ! 76.0 (C-22), 35.5 (C-6), 30.3 (C-5), 24.8 (C-8), and
39.6 (C-9) demonstrating that the tetrahydropyran and
terpenoid fragments were linked via the ethane frag-
ment C-7/C-8 to give the regular sesterterpenoid skele-
ton shown in 1 for barangcadoic acid A. The H-8/H8!
resonance at ! 1.38 showed HMBC correlations to
carbon resonances at ! 35.5 (C-6), 31.8 (C-7), 39.6
(C-9) and 134.7 (C-10) in agreement with the proposed
structure.
Sequential selective irradiation of the Me-25 (! 1.66),
Me-24 (! 1.58), and Me-23 (! 1.55) resonances in a
series of 1D NOESY experiments resulted in enhance-
ment of the H-20 (! 4.15), H-16 (! 2.08), and H-12 (!
2.10) resonances, respectively, establishing the E
configuration for the !10,11, !14,15 and !18,19 olefins in 1.
The H-3 resonance was a broad doublet with J=10.7
Hz indicating that it was axial. Similarly, H-22ax
appeared as a triplet with J=11.4 Hz indicating that
H-6 was also axial and, therefore, C-2 and C-7 were
trans to each other as shown in 1.
Rhopaloic acid A (2) (105 mg) gave an [M−H]− ion at
m/z 373.2743 in the negative ion HRFABMS spectrum
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appropriate for a molecular formula C24H38O3. Com-
parison of its NMR and optical rotation data with
literature values showed that it was identical to 2
previously isolated from the sponge Rhopaloeides sp.,5a
and subsequently synthesized by several groups.5b,c
Rhopaloic acids B (3) and C (4) were similarly iden-
tified by comparison of their spectroscopic data with
literature values for compounds 3 and 4 also isolated
from the same Rhopaloeides sp.6
Rhopaloic acids D (5) and E (6) were obtained in very
low yield as an inseparable mixture (0.2 mg) in the ratio
!6:4 (5:6). The mixture of compounds gave a [M+H]+
ion at m/z 391.2852 in the CIMS appropriate for a
molecular formula of C24H38O4, which contained one
more oxygen atom than the molecular formula of rho-
paloic acid (2). Examination of the NMR data (C6D6)
obtained for the mixture of 5 and 67,8 showed that both
molecules contained the substituted tetrahydropyran
fragment found in rhopaloic acid A (2) but differed
from 2 in the C-7 to C-19 fragment. A pair of singlet
olefinic resonances at ! 4.77 (H-24) and 4.94 (H-24!),
that each integrated for !0.5H and were correlated to
each other in the COSY spectrum and to a common
olefinic carbon resonance at ! 110.6 (C-24) in the
HMQC spectrum, showed that the major compound in
the mixture contained an olefinic methylene in the C-7
to C-19 fragment. HMBC correlations were observed
from the two olefinic methylene resonances to a carbi-
nol methine resonance at ! 75.4 (C-17) and to an
olefinic methyl resonance at ! 17.5 (C-19). COSY corre-
lations were observed between both of the olefinic
resonances at ! 4.77 (H-24) and 4.94 (H-24!) and an
olefinic methyl resonance at ! 1.62 (Me-19), and
between the ! 4.94 (H-24!) resonance and a carbinol
methine resonance at ! 3.89 (H-17). The above data
identified a disubstituted olefin with geminal methyl
and carbinol methine carbon substituents. This sub-
structure could only be accommodated at the terminus
of the C-7 to C-19 fragment as shown in the proposed
structure 5 for rhopaloic acid D.
A second pair of olefinic methylene proton resonances
that also integrated for !0.5H each, were found at !
4.88 (H-23) and 5.07 (H-23!) in the 1H spectrum of the
mixture of 5 and 6.7,8 Arguments based on COSY and
HMBC data allowed a tentative placement of an
olefinic methylene at C-14/C-23 and an allylic alcohol
at C-13 in rhopaloic acid E as shown in 6.
Rhopaloic acid F (7), obtained in only very small
amounts, gave a [M+H]+ ion at m/z 391.2839 in the
CIMS appropriate for a molecular formula of
C24H38O4, making it isomeric with rhopaloic acids D
(5) and E (6). Examination of its NMR data9 showed
that it also contained an olefinic methylene (C6D6; !
4.85 (H-22), 4.99 (H-22!), 109.2 (C-22)) and adjacent
allylic alcohol (! 3.78 (H-9), 75.1 (C-9)) unit identical to
the fragment found in the side chain of 6. The small
amount of 7 that was available made it impossible to
use NMR data to provide rigorous location of the
olefinic methylene and adjacent secondary alcohol func-
tionalities. However, since 7 was isomeric with 5 and 6
the only remaining position for the olefinic methylene
was at C-10/C22 and the COSY data precluded the
possibility of the carbinol methine being at C-11, lead-
ing to the proposed structure 7 for rhopaloic acid F.
Rhopaloic acid G (8) (0.1 mg) gave a [M+NH4]+ ion at
426.3219 in the CI MS appropriate for a molecular
formula of C24H40O5, which required only five sites of
unsaturation. Examination of the NMR data obtained
for 810 showed that it was simply an analog of rhopal-
poic acid A (2) in which one of the internal olefins in
the side chain had been converted to a vicinal diol. The
1H NMR spectrum of 8 contained only three olefinic
methyl (C6D6; ! 1.56, 1.63, 1.68) and two olefinic
methine (! 5.23, 5.29) resonances in addition to
aliphatic methyl (! 0.98) and carbinol methine (! 3.08)
resonances that could be assigned to the C-7 to C-19
fragment. The methyl resonance at ! 0.98 (Me-22)
showed HMBC correlations to carbon resonances at !
74.4 (C), 78.7 (CH), and 36.4 (CH2) demonstrating that
it was one of the internal olefins that had been con-
verted to a diol. The base peak in the CI spectrum
appeared at m/z 214.1198 (C11H18O4), consistent with "
cleavage of a C-9/C-10 diol resulting in the charge
residing on the C-1 to C-9 tetrahydropyran containing
fragment. The remainder of the NMR data was consis-
tent with the proposed structure 8 for rhopaloic acid G.
Barangcadoic acid A (1) has a regular sesterterpenoid
skeleton where the carbons C-1/C-2/C-21 form the head
of the starter unit in the assembly of the five isoprene
units. Rhopaloic acids A (1) to G (8) are nor-terpenoids
and on first analysis, because they contain the same
substituted tetrahydropyran fragment, they appear to
be related to the sesterterpenoid skeleton of barang-
cadoic acid A simply by loss of the C-20 carbon in 1.
However, the placement of the olefins in 2 to 8 suggests
that the head of the starter unit in the assembly of their
terpenoid skeletons should be the carbons C-18/C-19/
C-24. Resolution of this interesting biogenetic contra-
diction will likely have to await future biosynthetic
feeding experiments.
Barangcadoic acid A and rhopaloic acids A to D/E all
had IC50 values of !10 #g/mL in the RCE-protease
assay. Two colon tumor cell lines were used for in vitro
cytotoxicity testing. The LoVo cell line has a mutated
K-Ras and activated Ras pathway and consequently it
is quite sensitive to Ras pathway inhibitors. CaCo has
normal Ras and is generally resistant to Ras pathway
inhibitors. All of the compounds 1 to 5/6 had IC50
values !1–2 #g/mL against the LoVo cell line and
3–4-fold less activity against the CaCo cells, the
expected trend for RCE protease inhibitors. However,
the compounds are more active in the cell-based assays
(IC50!1 #g/mL) than in the enzyme assays (IC50!10
#g/mL), suggesting that the cytotoxic effect of the
compounds might result from hitting more than one
molecular target. Terpenoids 1 to 5/6 are apparently the
first reported natural product inhibitors of the RCE-
protease.11
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